Clinical Trial Update: A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of omalizumab on exercise capacity, physical activity, and sleep quality in adults with moderate-to-severe allergic asthma; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Moderate-to-severe Allergic Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Moderate-to-severe Allergic Asthma | Phase 4 | Status: TERMINATED | Results posted: 2022-03-15